Clinico-pathological evaluation of tumor budding in the oncological progression of colorectal cancer

被引:0
作者
Giordano, Pietro Giovanni [1 ,2 ,3 ]
Zelaya, Ana Gabriela Diaz [2 ]
Molina, Yari Yuritzi Aguilera [1 ,2 ,3 ]
Mostajo, Nestor Orlando Taboada [1 ]
Ramos, Yelene Ajete [1 ]
Garcia, Ricardo Ortega [1 ]
de Michelis, Esteban Peralta [1 ]
Diaz, Juan Carlos Meneu [1 ,2 ,3 ]
机构
[1] Hosp Univ Ruber Juan Bravo, Serv Cirugia Gen Visceral & Robot, Madrid, Spain
[2] Hosp Univ Ruber Juan Bravo, Serv Patol, Madrid, Spain
[3] Univ Europea Madrid, Fac Ciencias Biomed & Salud, Dept Med, Madrid, Spain
来源
MEDICINA CLINICA | 2024年 / 163卷 / 04期
关键词
Tumor budding; Colorectal cancer; Epithelial-mesenchymal transition; Cancer biology; GUIDELINES; COLON;
D O I
10.1016/j.medcli.2024.02.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Tumor budding (TB), defined as the presence of individual neoplastic cells or isolated groups of up to 4 cells at the front of tumor invasion, has become an adverse prognostic marker in colorectal cancer (CRC) in recent decades. The prognostic impact of TB in CRC remains not clearly defined and histological methods for its evaluation vary depending on the center. The objective of this study is to investigate the association between TB and CRC, in terms of oncological evolution and pathological stage. Methods: A retrospective observational study was conducted, including patients undergoing curative oncological surgery for CRC between January 2017 and December 2022. The effects of TB on disease-free survival (DFS) and overall survival (OS) were evaluated according to the Kaplan-Meier curves. Results: In 78 cases TB was described in the pathology report. TB was present in 56 patients (71.8%), divided into the following categories: low grade in 22 (39.3%), intermediate grade in 17 (30.4%) and high grade in 17 (30.4%). The proportion of patients who presented lymph node metastases, lympho-vascular and perineural invasion was significantly higher in patients with TB (26.8% vs 0%, P =.008; 41.1% vs 4.5%, P =.002; 16.1% vs 0% P =.054; respectively). DFS was 86.3% in low-grade TB, 75.3% in intermediate-grade TB, and 70.3% in high-grade TB. Cases with intermediate and high grade were associated with a shorter OS compared to the low grade group (93.7% and 75.4% vs 100% P =.012, respectively). Conclusion: These results suggest that TB expression may be a useful risk factor as a prognostic factor for the detection of lymph node metastasis, local recurrence, and distant metastasis in CRC. (c) 2024 The Author(s). Published by Elsevier Espana, S.L.U.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 26 条
[1]  
[Anonymous], 1954, Fukuoka Igaku Zasshi
[2]  
[Anonymous], 2023, Protocol for the examination of resection specimens from patients with invasive carcinoma of the breast
[3]   Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Argiles, G. ;
Tabernero, J. ;
Labianca, R. ;
Hochhauser, D. ;
Salazar, R. ;
Iveson, T. ;
Laurent-Puig, P. ;
Quirke, P. ;
Yoshino, T. ;
Taieb, J. ;
Martinelli, E. ;
Arnold, D. .
ANNALS OF ONCOLOGY, 2020, 31 (10) :1291-1305
[4]   Tumor Budding is an Independent Predictor of Outcome in AJCC/UICC Stage II Colorectal Cancer [J].
Betge, Johannes ;
Kornprat, Peter ;
Pollheimer, Marion J. ;
Lindtner, Richard A. ;
Schlemmer, Andrea ;
Rehak, Peter ;
Vieth, Michael ;
Langner, Cord .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (12) :3706-3712
[5]   The prognostic influence of tumour budding in Western patients with stage II colorectal cancer [J].
Cangucu, Augusto Leite ;
Valerio, Ediel ;
Peixoto, Roberto Bonfim Pimenta ;
Felismino, Tiago Cordeiro ;
de Mello, Celso Abdon Lopes ;
Neotti, Tatiane ;
Calsavara, Vinicius Fernando ;
de Macedo, Mariana Petaccia ;
Aguiar Junior, Samuel ;
Riechelmann, Rachel .
ECANCERMEDICALSCIENCE, 2020, 14
[6]   Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer [J].
Dawson, Heather ;
Galuppini, Francesca ;
Trager, Peter ;
Berger, Martin D. ;
Studer, Peter ;
Brugger, Lukas ;
Zlobec, Inti ;
Inderbitzin, Daniel ;
Lugli, Alessandro .
HUMAN PATHOLOGY, 2019, 85 :145-151
[7]   Morphology and prognostic value of tumor budding in rectal cancer after neoadjuvant radiotherapy [J].
Du, Changzheng ;
Xue, Weicheng ;
Li, Jiyou ;
Cai, Yong ;
Gu, Jin .
HUMAN PATHOLOGY, 2012, 43 (07) :1061-1067
[8]  
Guzinska-Ustymowicz K, 2004, ANTICANCER RES, V24, P2847
[9]   Japanese Society for Cancer of the Colon and Rectum (JS']JSCCR) guidelines 2019 for the treatment of colorectal cancer [J].
Hashiguchi, Yojiro ;
Muro, Kei ;
Saito, Yutaka ;
Ito, Yoshinori ;
Ajioka, Yoichi ;
Hamaguchi, Tetsuya ;
Hasegawa, Kiyoshi ;
Hotta, Kinichi ;
Ishida, Hideyuki ;
Ishiguro, Megumi ;
Ishihara, Soichiro ;
Kanemitsu, Yukihide ;
Kinugasa, Yusuke ;
Murofushi, Keiko ;
Nakajima, Takako Eguchi ;
Oka, Shiro ;
Tanaka, Toshiaki ;
Taniguchi, Hiroya ;
Tsuji, Akihito ;
Uehara, Keisuke ;
Ueno, Hideki ;
Yamanaka, Takeharu ;
Yamazaki, Kentaro ;
Yoshida, Masahiro ;
Yoshino, Takayuki ;
Itabashi, Michio ;
Sakamaki, Kentaro ;
Sano, Keiji ;
Shimada, Yasuhiro ;
Tanaka, Shinji ;
Uetake, Hiroyuki ;
Yamaguchi, Shigeki ;
Yamaguchi, Naohiko ;
Kobayashi, Hirotoshi ;
Matsuda, Keiji ;
Kotake, Kenjiro ;
Sugihara, Kenichi .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (01) :1-42
[10]   Tumor budding in colorectal cancer-ready for diagnostic practice?*'** [J].
Koelzer, Viktor H. ;
Zlobec, Inti ;
Lugli, Alessandro .
HUMAN PATHOLOGY, 2016, 47 (01) :4-19